Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1988 2
1989 2
1990 4
1991 1
1992 3
1993 3
1996 4
1997 1
1998 1
1999 1
2001 3
2002 1
2004 3
2006 1
2007 2
2008 1
2009 4
2010 3
2011 4
2012 2
2013 3
2014 2
2015 3
2016 6
2017 5
2018 4
2019 5
2020 1
2021 7
2022 4
2023 6
2024 12
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ruhlmann c
Search for Gumbmann C instead (2 results)
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Herrstedt J, Clark-Snow R, Ruhlmann CH, Molassiotis A, Olver I, Rapoport BL, Aapro M, Dennis K, Hesketh PJ, Navari RM, Schwartzberg L, Affronti ML, Garcia-Del-Barrio MA, Chan A, Celio L, Chow R, Fleury M, Gralla RJ, Giusti R, Jahn F, Iihara H, Maranzano E, Radhakrishnan V, Saito M, Sayegh P, Bosnjak S, Zhang L, Lee J, Ostwal V, Smit T, Zilic A, Jordan K, Scotté F; participants of the MASCC/ESMO Consensus Conference 2022. Electronic address: clinicalguidelines@esmo.org. Herrstedt J, et al. Among authors: ruhlmann ch. ESMO Open. 2024 Feb;9(2):102195. doi: 10.1016/j.esmoop.2023.102195. Epub 2024 Jan 11. ESMO Open. 2024. PMID: 38458657 Free PMC article.
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M; participants of the MASCC/ESMO Consensus Conference Copenhagen 2015. Roila F, et al. Among authors: ruhlmann ch. Ann Oncol. 2016 Sep;27(suppl 5):v119-v133. doi: 10.1093/annonc/mdw270. Ann Oncol. 2016. PMID: 27664248 No abstract available.
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.
Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, Forsea AM, Gebhardt C, Gershenwald JE, Hamid O, Hoeller C, Kandolf L, Kaufmann R, Kirkwood JM, Lebbé C, Long GV, Malvehy J, Martin-Algarra S, McArthur G, Neyns B, Richtig E, Robert C, Schadendorf D, Scolyer R, Sondak VK, Wainstein A, Weichenthal M, Nuti P; Melanoma World Society Study Group. Hauschild A, et al. Lancet Oncol. 2025 Jan;26(1):12-14. doi: 10.1016/S1470-2045(24)00627-2. Lancet Oncol. 2025. PMID: 39756440 No abstract available.
Response to Vitetta et al.
Nielsen SW, Ruhlmann CHB, Eckhoff L, Brønnum D, Herrstedt J, Dalton SO. Nielsen SW, et al. Among authors: ruhlmann chb. Support Care Cancer. 2022 Nov;30(11):8623-8624. doi: 10.1007/s00520-022-07356-0. Epub 2022 Sep 14. Support Care Cancer. 2022. PMID: 36100727 No abstract available.
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study.
Chan RJ, Knowles R, Ashbury FD, Bowen J, Chan A, Chin M, Olver I, Taylor C, Tinianov S, Alberti P, Bossi P, Brito-Dellan N, Cooksley T, Crawford GB, Dixit N, Fitch MI, Freedman JL, Ginex PK, Hart NH, Hertz DL, Jefford M, Koczwara B, Naito T, Orsey AD, Ruhlmann CH, Tsoukalas N, van den Hurk C, Van Sebille Y, Wardill HR, Scotte F, Lustberg M; Multinational Association of Supportive Care in Cancer (MASCC) Study Group Chairs. Chan RJ, et al. Among authors: ruhlmann ch. EClinicalMedicine. 2024 Sep 11;76:102825. doi: 10.1016/j.eclinm.2024.102825. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39309723 Free PMC article.
Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study.
Weichenthal M, Ellebaek E, Mangana J, Asher N, Gavrilova I, Kandolf L, Ugurel S, Hausschild A, Meier F, Leiter U, Livingstone E, Gebhardt C, Gutzmer R, Ruhlmann CH, Mahncke-Guldbrandt L, Haslund CA, Kopec S, Teterycz P, Bender M, Poudroux W, Muñoz-Couselo E, Berciano-Guerrero MA, Shalamanova G, DePalo DK, Brozić JM, Chiarion-Sileni V, Arance A, Ziogas D, Robert C, van de Velde AO, Gassama AA, Shapira R, BenBetzalel G, Grynberg S, Ramelyte E, Bertoldo F, DelPrete V, Gaudy-Marqueste C, Mohr P, Dummer R, Ascierto PA, Gogas H, Espinosa E, Lebbé C, Rutkowski P, Haanen J, Schadendorf D, Svane IM; EUMelaReg Consortium Members. Weichenthal M, et al. Among authors: ruhlmann ch. Eur J Cancer. 2025 May 2;220:115339. doi: 10.1016/j.ejca.2025.115339. Epub 2025 Mar 7. Eur J Cancer. 2025. PMID: 40090216 Free article.
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcome.
Jurlander RS, Guldbrandt LM, Holmstroem RB, Madsen K, Donia M, Haslund CA, Schmidt H, Bastholt L, Ruhlmann CH, Svane IM, Ellebaek E. Jurlander RS, et al. Among authors: ruhlmann ch. Eur J Cancer. 2024 Nov;212:115053. doi: 10.1016/j.ejca.2024.115053. Epub 2024 Sep 30. Eur J Cancer. 2024. PMID: 39405648 Free article.
107 results